This double-blind, placebo controlled study examined whether menthol inhaled from an electronic cigarette (e-cigarette) would change subjective and withdrawal alleviating effects of intravenous nicotine in young adult smokers.
Methods:
A total of 32 menthol-preferring smokers and 25 non-menthol-preferring smokers participated in the study that consisted of a random sequence of three different inhaled menthol conditions (0.0%, 0.5%, and 3.2%) across three test sessions (a single menthol condition per session). In each test session (performed at least 24 hours apart), a random order of saline, and two different nicotine infusions of 0.25 mg and 0.5 mg/70 kg of bodyweight were administered, one hour apart, concurrent with menthol inhalation.
Results:
While menthol did not alter the positive subjective effects of nicotine, menthol significantly enhanced aversive effects of nicotine in non-menthol-preferring smokers and reduced smoking urges in menthol-preferring smokers. In addition, menthol-preferring smokers reported blunted positive subjective responses to nicotine and less severe nicotine withdrawal after overnight nicotine deprivation. Finally, compared to non-menthol-preferring smokers, menthol-preferring smokers had a significantly lower baseline nicotine metabolite ratio indicating slower nicotine metabolism within our sample of menthol-preferring smokers.
Conclusions:
Our findings did not support an enhancement of nicotine’s positive subjective effects from inhaled menthol. However, as compared to non-menthol-preferring smokers, menthol-preferring smokers had blunted positive subjective responses to nicotine and reduced overnight withdrawal severity that may be partly due to inhibition of nicotine metabolism from chronic exposure to inhaled menthol. Collectively, these results reveal a more complex and nuanced role of inhaled menthol in smokers than previously recognized.
BiswasLHarrisonEGongY, et al. (2016) Enhancing effect of menthol on nicotine self-administration in rats. Psychopharmacology (Berl)233: 3417–3427.
8.
CaggiulaARDonnyECPalmatierMI, et al. (2009) The role of nicotine in smoking: A dual-reinforcement model. Nebr Symp Motiv55: 91–109.
9.
CoxLSTiffanySTChristenAG (2001) Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res3: 7–16.
10.
DawesJ (2014) Cigarette brand loyalty and purchase patterns: An examination using US consumer panel data. J Bus Res67: 1933–1943.
11.
DempseyDTutkaPJacobP 3rd,
, et al. (2004) Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther76: 64–72.
12.
DeVitoEEHermanAIWatersAJ, et al. (2014) Subjective, physiological, and cognitive responses to intravenous nicotine: Effects of sex and menstrual cycle phase. Neuropsychopharmacology39: 1431–1440.
13.
DeVitoEEValentineGWHermanAI, et al. (2016) Effect of menthol-preferring status on response to intravenous nicotine. Tob Regul Sci2: 317–328.
14.
FaganPPokhrelPHerzogTA, et al. (2016) Nicotine metabolism in young adult daily menthol and nonmenthol smokers. Nicotine Tob Res18: 437–446.
15.
FalconeMCaoWBernardoL, et al. (2016) Brain responses to smoking cues differ based on nicotine metabolism rate. Biol Psychiatry80: 190–197.
16.
FarcoJAGrundmannO (2013) Menthol–pharmacology of an important naturally medicinal “cool.”Mini Rev Med Chem13: 124–131.
17.
FarsalinosKERomagnaGTsiaprasD, et al. (2013) Evaluation of electronic cigarette use (vaping) topography and estimation of liquid consumption: Implications for research protocol standards definition and for public health authorities’ regulation. Int J Environ Res Public Health10: 2500–2514.
18.
FirstMBSpitzerRLGibbonM, et al. (1996) Structured Clinical Interview for DSM-IV Axis I Disorders–Patient Edition. New York: Biometrics Research Department, New York State Psychiatric Institute.
19.
GiovinoGAVillantiACMoweryPD, et al. (2015) Differential trends in cigarette smoking in the USA: Is menthol slowing progress?Tob Control24: 28–37.
20.
GoldensonNIKirpatrickMGGarrington-TrimisJL, et al. (2016) Effects of sweet flavorings and nicotine on the appeal and sensory properties of e-Cigarettes among young adult vapers: Application of a novel methodology. Drug Alcohol Depend1: 176–180.
21.
GordonSMBrinkmanMCMengRQ, et al. (2011) Effect of cigarette menthol content on mainstream smoke emissions. Chem Res Toxicol24: 1744–1753.
22.
GuyattARKirkhamAJBaldryAG, et al. (1989) How does puffing behavior alter during the smoking of a single cigarette?Pharmacol Biochem Behav33: 189–195.
23.
HansMWilhelmMSwandullaD (2012) Menthol suppresses nicotinic acetylcholine receptor functioning in sensory neurons via allosteric modulation. Chem Senses37: 463–469.
24.
HarrisonEBiswasLRamachandramA, et al. (2017) Effects of menthol and its interaction with nicotine-conditioned cue on nicotine-seeking behavior in rats. Psychopharmacology234: 3443–3453.
HendersonBJWallTRHenleyBM, et al. (2017) Menthol enhances nicotine reward-related behavior by potentiating nicotine-induced changes in nAChR function, nAChR upregulation, and DA neuron excitability. Neuropsychopharmacology42: 2285–2291.
27.
HughesJRHatsukamiD (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry43: 289–294.
28.
JatlowPValentineGGueorguievaR, et al. (2018) Plasma menthol glucuronide as a biomarker of acute menthol inhalation. Tob Regul Sci4: 586–591.
29.
KolonenSTuomistoJPuustinenP, et al. (1992) Puffing behavior during the smoking of a single cigarette in a naturalistic environment. Pharmacol Biochem Behav41: 701–706.
30.
LallaiVFowlerCD (2017) More than just chillin’: Interactive effects of menthol and nicotine in drug reward. Neuropsychopharmacology42: 2283–2284.
31.
LiuBFanLBalakrishnaS, et al. (2013) TRPM8 is the principal mediator of menthol-induced analgesia of acute and inflammatory pain. Pain154: 2169–2177.
32.
MacDougallJMFandrickKZhangX, et al. (2003) Inhibition of human liver microsomal (S)-nicotine oxidation by (-)-menthol and analogues. Chem Res Toxicol16: 988–993.
33.
MelloNKPeltierMRDuncansonH (2013) Nicotine levels after IV nicotine and cigarette smoking in men. Exp Clin Psychopharmacol21: 188–195.
34.
MoreanMEde WitHKingAC, et al. (2013) The drug effects questionnaire: Psychometric support across three drug types. Psychopharmacology (Berl)227: 177–192.
35.
PanRTianYGaoR, et al. (2012) Central mechanisms of menthol-induced analgesia. J Pharmacol Exp Ther343: 661–672.
36.
PeierAMMoqrichAHergardenAC, et al. (2002) A TRP channel that senses cold stimuli and menthol. Cell108: 705–715.
37.
PerkinsKAKunkleNKarelitzJL (2017) Threshold dose for behavioral discrimination of cigarette nicotine content in menthol vs. non-menthol smokers. Psychopharmcology (Berl)234: 1255–1265.
38.
RobinsonCDPickworthWBHeishmanSJ, et al. (2014) The acute tobacco withdrawal syndrome among black smokers. Psychol Addict Behav28: 173–181.
39.
RockVJDavisSPThorneSL, et al. (2010) Menthol cigarette use among racial and ethnic groups in the United States, 2004-2008. Nicotine Tob Res12(Suppl 2): S117–S124.
40.
RosbrookKGreenBG (2016) Sensory effects of menthol and nicotine in an E-cigarette. Nicotine Tob Res18: 1588–1595.
41.
RoseJEBehmFM (2004) Extinguishing the rewarding value of smoke cues: Pharmacological and behavioral treatments. Nicotine Tob Res6: 523–532.
42.
RoseJEBehmFMWestmanEC, et al. (1999) Arterial nicotine kinetics during cigarette smoking and intravenous nicotine administration: Implications for addiction. Drug Alcohol Depend56: 99–107.
43.
RoseJESalleyABehmFM, et al. (2010) Reinforcing effects of nicotine and non-nicotine components of cigarette smoke. Psychopharmacology (Berl)210: 1–12.
44.
SofuogluMHermanAINadimH, et al. (2012) Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine. Neuropsychopharmacology37: 1509–1516.
45.
SofuogluMMitchellEMooneyM (2009) Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers. Hum Psychopharmacol24: 559–564.
46.
SofuogluMMooneyM (2009) Subjective responses to intravenous nicotine: Greater sensitivity in women than in men. Exp Clin Psychopharmacol17: 63–69.
47.
SofuogluMMouratidisMMooneyM (2011) Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers. Psychoneuroendocrinology36: 123–132.
48.
SofuogluMMouratidisMYooS, et al. (2005) Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers. Psychopharmacology (Berl)181: 504–510.
49.
SofuogluMYooSHillKP, et al. (2008) Self-administration of intravenous nicotine in male and female cigarette smokers. Neuropsychopharmacology33: 715–720.
50.
SorgeREPierreVJClarkePB (2009) Facilitation of intravenous nicotine self-administration in rats by a motivationally neutral sensory stimulus. Psychopharmacology207: 191–200.
51.
TiffanySTDrobesDJ (1991) The development and initial validation of a questionnaire on smoking urges. Br J Addict86: 1467–1476.
52.
TonHTSmartAEAguilarBL (2015) Menthol enhances the desensitization of human alpha3beta4 nicotinic acetylcholine receptors. Mol Pharmacol88: 256–264.
53.
UhlGRWaltherDBehmFM, et al. (2011) Menthol preference among smokers: Association with TRPA1 variants. Nicotine Tob Res13: 1311–1315.
54.
UmezuTSakataAItoH (2001) Ambulation-promoting effect of peppermint oil and identification of its active constituents. Pharmacol Biochem Behav69: 383–390.
VillantiACMoweryPDDelnevoCD, et al. (2016) Changes in the prevalence and correlates of menthol cigarette use in the USA, 2004-2014. Tob Control25(Suppl 2):ii14–ii20.
57.
WangTWangBChenH (2014) Menthol facilitates the intravenous self-administration of nicotine in rats. Front Behav Neurosci8: 437.
58.
WickhamRJNunesEJHughleyS, et al. (2018) Evaluating oral flavorant effects on nicotine self-administration behavior and phasic dopamine signaling. Neuropharmacology128: 33–42.
59.
ZhangXBJiangPGongN, et al. (2008) A-type GABA receptor as a central target of TRPM8 agonist menthol. PLoS One3: e3386.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
